ODDB.org: Open Drug Database

Swissmedic Registration	70189	Date of registration	23.07.2025
Company name	Amgen Switzerland AG	Revision date
		Valid until	22.07.2030
Indication		Date of market entry
Index Therapeuticus (BSV)		Revocation Date
Index Therapeuticus (Swissmedic)	07.15.	Information for professionals

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Wezenla 45 mg/0.5 ml	Injektionslösung	Injection solution (Ustekinumabum 45mg / 0.5ml)	L04AC05

2026	©ywesee GmbH